Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia

Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia

Background: Citrin, encoded by SLC25A13, is a component of the malate-aspartate shuttle, which is the main NADH-transporting system in the liver. Citrin deficiency causes neonatal intrahepatic cholestasis (NICCD), which usually resolves within the first year of life. However, small numbers of adults...

Full description

Bibliographic Details
Main Authors: Kiyoshi Hayasaka, Chikahiko Numakura, Kentaro Toyota, Satoru Kakizaki, Hisayoshi Watanabe, Hiroaki Haga, Hiroshi Takahashi, Yoshimi Takahashi, Mieko Kaneko, Mitsunori Yamakawa, Hiroyuki Nunoi, Takeo Kato, Yoshiyuki Ueno, Masatomo Mori
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
Neonatal intrahepatic cholestasis (NICCD)
Adult-onset type II citrullinemia (CTLN2)
Citrin deficiency
Medium-chain triglycerides (MCT)
SLC25A13
Malate-aspartate shuttle
Online Access:http://www.sciencedirect.com/science/article/pii/S2214426913000074

Internet

http://www.sciencedirect.com/science/article/pii/S2214426913000074

Similar Items